vs

Side-by-side financial comparison of Arteris, Inc. (AIP) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $13.3M, roughly 1.5× OCULAR THERAPEUTIX, INC). Arteris, Inc. runs the higher net margin — -42.2% vs -488.0%, a 445.7% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs -22.4%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-57.1M). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs -5.3%).

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

AIP vs OCUL — Head-to-Head

Bigger by revenue
AIP
AIP
1.5× larger
AIP
$20.1M
$13.3M
OCUL
Growing faster (revenue YoY)
AIP
AIP
+52.4% gap
AIP
30.0%
-22.4%
OCUL
Higher net margin
AIP
AIP
445.7% more per $
AIP
-42.2%
-488.0%
OCUL
More free cash flow
AIP
AIP
$60.1M more FCF
AIP
$3.0M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
AIP
AIP
Annualised
AIP
24.7%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIP
AIP
OCUL
OCUL
Revenue
$20.1M
$13.3M
Net Profit
$-8.5M
$-64.7M
Gross Margin
90.8%
88.0%
Operating Margin
-42.0%
-526.5%
Net Margin
-42.2%
-488.0%
Revenue YoY
30.0%
-22.4%
Net Profit YoY
-3.7%
-33.6%
EPS (diluted)
$-0.19
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIP
AIP
OCUL
OCUL
Q4 25
$20.1M
$13.3M
Q3 25
$17.4M
$14.5M
Q2 25
$16.5M
$13.5M
Q1 25
$16.5M
$10.7M
Q4 24
$15.5M
$17.1M
Q3 24
$14.7M
$15.4M
Q2 24
$14.6M
$16.4M
Q1 24
$12.9M
$14.8M
Net Profit
AIP
AIP
OCUL
OCUL
Q4 25
$-8.5M
$-64.7M
Q3 25
$-9.0M
$-69.4M
Q2 25
$-9.1M
$-67.8M
Q1 25
$-8.1M
$-64.1M
Q4 24
$-8.2M
$-48.4M
Q3 24
$-7.7M
$-36.5M
Q2 24
$-8.3M
$-43.8M
Q1 24
$-9.4M
$-64.8M
Gross Margin
AIP
AIP
OCUL
OCUL
Q4 25
90.8%
88.0%
Q3 25
89.9%
87.8%
Q2 25
89.4%
85.6%
Q1 25
90.8%
88.2%
Q4 24
89.8%
92.8%
Q3 24
90.1%
89.9%
Q2 24
90.0%
90.8%
Q1 24
88.7%
91.0%
Operating Margin
AIP
AIP
OCUL
OCUL
Q4 25
-42.0%
-526.5%
Q3 25
-50.1%
-472.3%
Q2 25
-50.0%
-502.6%
Q1 25
-46.6%
-597.5%
Q4 24
-45.9%
-296.1%
Q3 24
-53.8%
-298.2%
Q2 24
-51.1%
-265.1%
Q1 24
-70.5%
-214.0%
Net Margin
AIP
AIP
OCUL
OCUL
Q4 25
-42.2%
-488.0%
Q3 25
-51.6%
-477.3%
Q2 25
-55.3%
-503.9%
Q1 25
-49.1%
-598.7%
Q4 24
-53.0%
-283.3%
Q3 24
-52.2%
-236.6%
Q2 24
-57.2%
-266.3%
Q1 24
-72.6%
-438.9%
EPS (diluted)
AIP
AIP
OCUL
OCUL
Q4 25
$-0.19
$-0.27
Q3 25
$-0.21
$-0.38
Q2 25
$-0.22
$-0.39
Q1 25
$-0.20
$-0.38
Q4 24
$-0.19
$-0.25
Q3 24
$-0.20
$-0.22
Q2 24
$-0.22
$-0.26
Q1 24
$-0.25
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIP
AIP
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$33.9M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-14.6M
$654.3M
Total Assets
$115.0M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIP
AIP
OCUL
OCUL
Q4 25
$33.9M
$737.1M
Q3 25
$39.0M
$344.8M
Q2 25
$38.0M
$391.1M
Q1 25
$42.3M
$349.7M
Q4 24
$43.8M
$392.1M
Q3 24
$48.7M
$427.2M
Q2 24
$45.8M
$459.7M
Q1 24
$44.8M
$482.9M
Stockholders' Equity
AIP
AIP
OCUL
OCUL
Q4 25
$-14.6M
$654.3M
Q3 25
$-11.4M
$258.2M
Q2 25
$-7.5M
$305.9M
Q1 25
$-4.8M
$265.9M
Q4 24
$-1.2M
$315.3M
Q3 24
$2.2M
$352.0M
Q2 24
$5.3M
$377.7M
Q1 24
$9.5M
$408.0M
Total Assets
AIP
AIP
OCUL
OCUL
Q4 25
$115.0M
$808.1M
Q3 25
$107.7M
$410.9M
Q2 25
$106.9M
$451.3M
Q1 25
$98.3M
$405.9M
Q4 24
$106.1M
$457.9M
Q3 24
$97.7M
$490.4M
Q2 24
$96.4M
$517.1M
Q1 24
$101.4M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIP
AIP
OCUL
OCUL
Operating Cash FlowLast quarter
$3.2M
$-54.2M
Free Cash FlowOCF − Capex
$3.0M
$-57.1M
FCF MarginFCF / Revenue
15.1%
-430.9%
Capex IntensityCapex / Revenue
0.7%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIP
AIP
OCUL
OCUL
Q4 25
$3.2M
$-54.2M
Q3 25
$3.2M
$-50.7M
Q2 25
$-2.5M
$-55.2M
Q1 25
$2.9M
$-44.7M
Q4 24
$-2.6M
$-39.4M
Q3 24
$1.1M
$-36.6M
Q2 24
$311.0K
$-24.8M
Q1 24
$477.0K
$-33.9M
Free Cash Flow
AIP
AIP
OCUL
OCUL
Q4 25
$3.0M
$-57.1M
Q3 25
$2.5M
$-56.7M
Q2 25
$-2.8M
$-56.5M
Q1 25
$2.7M
$-46.6M
Q4 24
$-2.7M
$-39.6M
Q3 24
$1.1M
$-36.6M
Q2 24
$264.0K
$-25.5M
Q1 24
$281.0K
$-34.1M
FCF Margin
AIP
AIP
OCUL
OCUL
Q4 25
15.1%
-430.9%
Q3 25
14.2%
-390.0%
Q2 25
-17.2%
-419.7%
Q1 25
16.2%
-435.6%
Q4 24
-17.3%
-232.0%
Q3 24
7.4%
-237.6%
Q2 24
1.8%
-155.4%
Q1 24
2.2%
-231.1%
Capex Intensity
AIP
AIP
OCUL
OCUL
Q4 25
0.7%
21.4%
Q3 25
4.1%
41.2%
Q2 25
2.2%
9.3%
Q1 25
1.1%
18.1%
Q4 24
0.3%
1.2%
Q3 24
0.2%
0.6%
Q2 24
0.3%
4.5%
Q1 24
1.5%
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons